Expedited PublicationBaroreflex Activation Therapy Lowers Blood Pressure in Patients With Resistant Hypertension: Results From the Double-Blind, Randomized, Placebo-Controlled Rheos Pivotal Trial
Under an Elsevier user license
open archive
Key Words
baroreflex
medical device
resistant hypertension
Abbreviations and Acronyms
BAT
baroreflex activation therapy
BP
blood pressure
DMC
data monitoring committee
HTN
hypertension
SBP
systolic blood pressure
Cited by (0)
This study was funded by CVRx, Inc., Minneapolis, Minnesota. Drs. Bisognano, Bakris, Nadim, Sanchez, Kroon, de Leeuw, and Sica have received research grant support from CVRx and are currently serving as consultants/advisors for CVRx. Dr. Bakris is an investigator for Relapysa and Medtronic; a consultant for Abbott, Takeda, Lilly, and Servier; a board member of the National Kidney Foundation; and the president of the American Society of Hypertension. Ms. Schafer is a former employee of CVRx, Inc., and is currently a paid consultant to CVRx, Inc.
Copyright © 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.